Many of these genes were predicted to be TFBS and loss of function pathogenic variants in several of these TFBS target genes (ALX4, NELL1, MSX2, RUNX2) result in delayed skeletal ossification, whereas gain of function (GOF) variants in the same genes result in accelerated ossification and craniosynostosis [5]. The gene discussed is MSX2; the disease is craniosynostosis.